Costs of Development. Unless otherwise agreed and except as is otherwise provided in Section 2.03(d), all Development Expenses incurred for a Product shall be borne by Alliance; PROVIDED, HOWEVER, that in the event either Schering, in its sole determination, or the Steering Committee determines that additional Development of the Product beyond the scope described in this Agreement and in the Development Plan is necessary and such decision causes a material increase in Development Expenses, then such additional Development Expenses shall be borne by Schering.
Appears in 2 contracts
Sources: License Agreement (Alliance Pharmaceutical Corp), License Agreement (Alliance Pharmaceutical Corp)